Showing results (361-370 of 648) with videos related to
Sort By:
Pageof 65
Journal of Biomolecular Structure & Dynamics|June 8, 2012
Theoretical Design, Chemical Synthesis and Footprinting Analysis of a Novel Peptide Derivative of the Intercalator 7-H Pyridocarbazole Targeted Towards the Major Groove of DNANohad Gresh, Brigitte René, Xiao-Wen Hui, et al.Journal of Medicinal Chemistry|June 1, 1989
Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptorsB Charpentier, A Dor, P Roy, et al.Journal of Medicinal Chemistry|September 1, 1986
Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazolesE Lescot, G Muzard, J Markovits, et al.European Journal of Pain (London, England)|May 3, 2003
Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cordJaroslava Buritova, Stéphanie Le Guen, Marie-Claude Fournié-Zaluski, et al.Journal of Molecular Biology|May 28, 2003
Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteinsLeonora Poljak, Susan M Batson, Damien Ficheux, et al.Life Sciences|January 1, 1983
Pain control by endogenous enkephalins is mediated by mu opioid receptorsP Chaillet, A Coulaud, M C Fournié-Zaluski, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1984
[Regional distribution of enkephalinase in the rat brain by autoradiography]G Waksman, E Hamel, R Bouboutou, et al.Pharmacology Research & Perspectives|February 19, 2015
Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled painElisabeth Bonnard, Hervé Poras, Xavier Nadal, et al.European Journal of Pharmacology|May 20, 1998
Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levelsW González, J M Soleilhac, M C Fournié-Zaluski, et al.The Biochemical Journal|December 2, 2004
The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domainSarah Bourbigot, Hervé Beltz, Jérôme Denis, et al.Pageof 65